Page last updated: 2024-10-26

eicosapentaenoic acid ethyl ester and Cancer of Pancreas

eicosapentaenoic acid ethyl ester has been researched along with Cancer of Pancreas in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akita, H1
Takahashi, H1
Asukai, K1
Tomokuni, A1
Wada, H1
Marukawa, S1
Yamasaki, T1
Yanagimoto, Y1
Takahashi, Y1
Sugimura, K1
Yamamoto, K1
Nishimura, J1
Yasui, M1
Omori, T1
Miyata, H1
Ochi, A1
Kagawa, A1
Soh, Y1
Taniguchi, Y1
Ohue, M1
Yano, M1
Sakon, M1

Trials

1 trial available for eicosapentaenoic acid ethyl ester and Cancer of Pancreas

ArticleYear
The utility of nutritional supportive care with an eicosapentaenoic acid (EPA)-enriched nutrition agent during pre-operative chemoradiotherapy for pancreatic cancer: Prospective randomized control study.
    Clinical nutrition ESPEN, 2019, Volume: 33

    Topics: Aged; Chemoradiotherapy; Dietary Supplements; Eicosapentaenoic Acid; Female; Humans; Male; Middle Ag

2019